185 related articles for article (PubMed ID: 27113979)
1. Cytogenetic damage of radiotherapy in long-term head and neck cancer survivors.
Unal D; Kiraz A; Avci D; Tasdemir A; Unal TD; Cagli S; Eroglu C; Yuce I; Ozcan I; Kaplan B
Int J Radiat Biol; 2016 Jul; 92(7):364-70. PubMed ID: 27113979
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Cytogenetic Alterations in Peripheral Blood Lymphocytes of Esophageal Cancer Patients Treated with Radiotherapy or Chemoradiotherapy using Cytokinesis-Blocked Micronucleus Assay.
Emamgholizadeh Minaei S; Mozdarani H; Motazakker M; Mansouri M; R Aghamiri SM
Acta Med Iran; 2016 Jan; 54(1):9-14. PubMed ID: 26853285
[TBL] [Abstract][Full Text] [Related]
3. Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study.
Driessen CM; de Boer JP; Gelderblom H; Rasch CR; de Jong MA; Verbist BM; Melchers WJ; Tesselaar ME; van der Graaf WT; Kaanders JH; van Herpen CM
Eur J Cancer; 2016 Jan; 52():77-84. PubMed ID: 26655558
[TBL] [Abstract][Full Text] [Related]
4. Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: a systematic review of the literature.
Theunissen EA; Bosma SC; Zuur CL; Spijker R; van der Baan S; Dreschler WA; de Boer JP; Balm AJ; Rasch CR
Head Neck; 2015 Feb; 37(2):281-92. PubMed ID: 24478269
[TBL] [Abstract][Full Text] [Related]
5. Conventional radiotherapy versus concurrent chemoradiotherapy versus accelerated radiotherapy in locoregionally advanced carcinoma of head and neck: Results of a prospective randomized trial.
Ghosh-Laskar S; Kalyani N; Gupta T; Budrukkar A; Murthy V; Sengar M; Chaukar D; Pai P; Chaturvedi P; D'Cruz A; Agarwal J
Head Neck; 2016 Feb; 38(2):202-7. PubMed ID: 25224814
[TBL] [Abstract][Full Text] [Related]
6. Increased micronucleus frequency in peripheral blood lymphocytes contributes to cancer risk in the methyl isocyanate-affected population of Bhopal.
Senthilkumar CS; Akhter S; Malla TM; Sah NK; Ganesh N
Asian Pac J Cancer Prev; 2015; 16(10):4409-19. PubMed ID: 26028107
[TBL] [Abstract][Full Text] [Related]
7. Micronucleus frequencies in peripheral blood lymphocytes of children with chronic kidney disease.
Cakmak Demircigil G; Aykanat B; Fidan K; Gulleroglu K; Bayrakci US; Sepici A; Buyukkaragoz B; Karakayali H; Haberal M; Baskin E; Buyan N; Burgaz S
Mutagenesis; 2011 Sep; 26(5):643-50. PubMed ID: 21669938
[TBL] [Abstract][Full Text] [Related]
8. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
[TBL] [Abstract][Full Text] [Related]
9. Micronucleus frequencies in lymphocytes and buccal epithelial cells from patients having head and neck cancer and their first-degree relatives.
Burgaz S; Coskun E; Demircigil GC; Kocabas NA; Cetindag F; Sunter O; Edinsel H
Mutagenesis; 2011 Mar; 26(2):351-6. PubMed ID: 21248276
[TBL] [Abstract][Full Text] [Related]
10. Study of cytogenetic toxicity of low-dose radioiodine therapy in hyperthyroid patients using a micronuclei assay.
Parida GK; Bal C; Dada R; Tripathi M; Dwivedi S
Nucl Med Commun; 2016 Aug; 37(8):800-4. PubMed ID: 27081713
[TBL] [Abstract][Full Text] [Related]
11. Peripheral blood lymphocyte decrease and micronucleus yields during radiotherapy.
Catena C; Parasacchi P; Conti D; Sgura A; Trenta G; Righi E; Trinci MM; Trinci M
Int J Radiat Biol; 1997 Nov; 72(5):575-85. PubMed ID: 9374437
[TBL] [Abstract][Full Text] [Related]
12. Baseline and therapy-induced chromosome damages in peripheral blood lymphocytes of breast cancer patients assessed by the micronucleus assay.
Milosevic-Djordjevic O; Stosic I; Vuckovic M; Grujicic D; Marinkovic D
J BUON; 2011; 16(3):437-43. PubMed ID: 22006746
[TBL] [Abstract][Full Text] [Related]
13. Persistence of micronuclei in lymphocytes of cancer patients after radiotherapy.
Lee TK; Allison RR; O'Brien KF; Naves JL; Karlsson UL; Wiley AL
Radiat Res; 2002 Jun; 157(6):678-84. PubMed ID: 12005547
[TBL] [Abstract][Full Text] [Related]
14. Reirradiation for head-and-neck cancer: delicate balance between effectiveness and toxicity.
Hoebers F; Heemsbergen W; Moor S; Lopez M; Klop M; Tesselaar M; Rasch C
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e111-8. PubMed ID: 21362581
[TBL] [Abstract][Full Text] [Related]
15. Assessment of voice, speech, and related quality of life in advanced head and neck cancer patients 10-years+ after chemoradiotherapy.
Kraaijenga SA; Oskam IM; van Son RJ; Hamming-Vrieze O; Hilgers FJ; van den Brekel MW; van der Molen L
Oral Oncol; 2016 Apr; 55():24-30. PubMed ID: 26874554
[TBL] [Abstract][Full Text] [Related]
16. Predictors of severe late radiotherapy-related toxicity after hyperfractionated radiotherapy with or without concomitant cisplatin in locally advanced head and neck cancer. Secondary retrospective analysis of a randomized phase III trial (SAKK 10/94).
Ghadjar P; Simcock M; Zimmermann F; Betz M; Bodis S; Bernier J; Studer G; Aebersold DM;
Radiother Oncol; 2012 Aug; 104(2):213-8. PubMed ID: 22726581
[TBL] [Abstract][Full Text] [Related]
17. Sudden death after operation, radiotherapy or chemoradiotherapy for head and neck cancer.
Nagano H; Kyutoku T; Matsumoto H; Kurono Y
Otolaryngol Pol; 2022 Dec; 77(1):1-5. PubMed ID: 36805515
[TBL] [Abstract][Full Text] [Related]
18. Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative disease.
Harrington K; Berrier A; Robinson M; Remenar E; Housset M; de Mendoza FH; Fayette J; Mehanna H; El-Hariry I; Compton N; Franklin N; Biswas-Baldwin N; Lau M; Legenne P; Kumar R
Eur J Cancer; 2013 May; 49(7):1609-18. PubMed ID: 23265705
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome and morbidity after treatment with accelerated radiotherapy and weekly cisplatin for locally advanced head-and-neck cancer: results of a multidisciplinary late morbidity clinic.
Rütten H; Pop LA; Janssens GO; Takes RP; Knuijt S; Rooijakkers AF; van den Berg M; Merkx MA; van Herpen CM; Kaanders JH
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):923-9. PubMed ID: 21095074
[TBL] [Abstract][Full Text] [Related]
20. Follow-up in the micronucleus frequencies and its subsets in human population with chronic low-dose gamma-irradiation exposure.
Chang WP; Tsai MS; Hwang JS; Lin YP; Hsieh WA; Huang SY
Mutat Res; 1999 Jul; 428(1-2):99-105. PubMed ID: 10517983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
